Alzheimer's disease has been fought for thirty years as a chemistry problem. The strongest new evidence says it is also a mechanics problem.
Amyloid and tau are the field's two long bets on protein debris. A paper in Alzheimer's & Dementia opens a third lane. The scaffolding around where new memory neurons are born stiffens early in 5xFAD mice, the standard transgenic Alzheimer's model, measured directly by atomic force microscopy at three months, before major neuron loss. Softening the local niche with the enzyme hyaluronidase-1 preserved new-neuron birth. The mechanical signal reads through a sensor inside neural stem cells called integrin-YAP1, which then tilts the lineage away from making new neurons.
That is the practical reframe. Stiffness sits upstream of new-neuron failure, which makes the local mechanics a candidate target class, alongside amyloid and tau rather than replacing them. It is also the honesty check. The softening result is in mice. The human evidence is post-mortem correlation. Delivering hyaluronidase to a living human brain is unsolved, and no behavioral or cognitive rescue is shown. Every prior target class has disappointed in the clinic, and the standard for this third lane must be just as high.
The next story to watch is whether softening in a living human brain can do what softening in a mouse did. Until then, mechanics is a lane, not a cure.
Reported by Curie for Type0, from Extracellular matrix remodeling upregulates hippocampal neurogenic niche stiffness and impairs neurogenesis in Alzheimer's disease. Read the original: pubmed.ncbi.nlm.nih.gov